Industry: Consumer Goods
Published Date: 2025-11-18
Pages: 127 Pages
Report ld: 5485979
Request Sample
Customized Report
Nicotinamide Mononucleotide (NMN) Cosmetics Market Size(US$)

CAGR 2025-2031
20.8%
Market Size,2031
USD 1,158
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Nicotinamide Mononucleotide (NMN) Cosmetics was estimated to be worth US$ 305 million in 2024 and is forecast to a readjusted size of US$ 1158 million by 2031 with a CAGR of 20.8% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Nicotinamide Mononucleotide (NMN) Cosmetics cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Nicotinamide Mononucleotide (NMN) Cosmetics market refers to the segment of skincare and personal care products in which NMN is used as a core functional active to deliver anti-aging, moisturizing and “skin vitality” benefits. In this context, NMN is positioned as a next-generation derivative of the vitamin B3 family and a direct precursor of NAD⁺, a coenzyme involved in cellular energy metabolism and DNA repair; patents on NMN-containing cosmetic compositions describe its use to provide long-lasting moisturization and to improve visible signs of skin aging such as wrinkles, sagging and roughness. The market therefore covers any cosmetic product where NMN is deliberately added and highlighted in the formula or marketing story—serums, lotions, creams, facial masks, eye products, hand or body creams, and sometimes specialty items such as biocellulose masks or treatment ampoules—rather than oral supplements or general NAD⁺ boosters, which belong to the nutraceutical category.
The Nicotinamide Mononucleotide (NMN) Cosmetics industry chain runs from upstream suppliers of cosmetic-grade NMN (derived from vitamin B3/nicotinamide and fermentation raw materials), emollients, humectants, surfactants, packaging and mask substrates, through midstream cosmetic formulators and OEM/ODM manufacturers that develop serums, creams, facial masks, eye and body products, to downstream brand owners, e-commerce platforms, pharmacies, beauty retailers, clinics/spas and end-consumers using NMN cosmetics for anti-aging, moisturizing, brightening and “skin vitality” care.
In 2024, global Nicotinamide Mononucleotide (NMN) Cosmetics production reached approximately 17.4 million units, with an average global market price of around US$ 17.6 per unit. The global single-line production capacity ranges from 500 to1000 k units per year. The industry's gross profit margin is approximately 30%-35%.
North American market for Nicotinamide Mononucleotide (NMN) Cosmetics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nicotinamide Mononucleotide (NMN) Cosmetics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Nicotinamide Mononucleotide (NMN) Cosmetics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Nicotinamide Mononucleotide (NMN) Cosmetics include Natuore Recover, Mirailab Bioscience, Eurea, LUERLING, RubyBerries, Winkey Technology, GeneHarbor, Bontac, EffePharm, Bloomage Biotechnology, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide (NMN) Cosmetics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nicotinamide Mononucleotide (NMN) Cosmetics by region & country, by Type, and by Application.
The Nicotinamide Mononucleotide (NMN) Cosmetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN) Cosmetics.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nicotinamide Mononucleotide (NMN) Cosmetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nicotinamide Mononucleotide (NMN) Cosmetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nicotinamide Mononucleotide (NMN) Cosmetics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Nicotinamide Mononucleotide (NMN) Cosmetics Product Introduction
1.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Size Forecast
1.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value (2020-2031)
1.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume (2020-2031)
1.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Price (2020-2031)
1.3 Nicotinamide Mononucleotide (NMN) Cosmetics Market Trends & Drivers
1.3.1 Nicotinamide Mononucleotide (NMN) Cosmetics Industry Trends
1.3.2 Nicotinamide Mononucleotide (NMN) Cosmetics Market Drivers & Opportunity
1.3.3 Nicotinamide Mononucleotide (NMN) Cosmetics Market Challenges
1.3.4 Nicotinamide Mononucleotide (NMN) Cosmetics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Players Revenue Ranking (2024)
2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Company (2020-2025)
2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Players Sales Volume Ranking (2024)
2.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Company Players (2020-2025)
2.5 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Company (2020-2025)
2.6 Key Manufacturers Nicotinamide Mononucleotide (NMN) Cosmetics Manufacturing Base and Headquarters
2.7 Key Manufacturers Nicotinamide Mononucleotide (NMN) Cosmetics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nicotinamide Mononucleotide (NMN) Cosmetics
2.9 Nicotinamide Mononucleotide (NMN) Cosmetics Market Competitive Analysis
2.9.1 Nicotinamide Mononucleotide (NMN) Cosmetics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Nicotinamide Mononucleotide (NMN) Cosmetics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) Cosmetics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Online
3.1.2 Offline
3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type
3.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Type (2020-2031)
3.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Type (%) (2020-2031)
3.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Type
3.3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Type (2020-2031)
3.3.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Type (%) (2020-2031)
3.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Type (2020-2031)
4 Segmentation by Application Area
4.1 Introduction by Application Area
4.1.1 Facial Care
4.1.2 Body Care
4.1.3 Hair Care
4.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application Area
4.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application Area (2020 VS 2024 VS 2031)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Application Area (2020-2031)
4.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Application Area (%) (2020-2031)
4.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Application Area
4.3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Application Area (2020 VS 2024 VS 2031)
4.3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Application Area (2020-2031)
4.3.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Application Area (%) (2020-2031)
4.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Application Area (2020-2031)
5 Segmentation by Target Consumer Group
5.1 Introduction by Target Consumer Group
5.1.1 20s–30s Consumers
5.1.2 30s–40s Consumers
5.1.3 Men Consumers
5.1.4 Others
5.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Target Consumer Group
5.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Target Consumer Group (2020 VS 2024 VS 2031)
5.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Target Consumer Group (2020-2031)
5.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Target Consumer Group (%) (2020-2031)
5.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Target Consumer Group
5.3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Target Consumer Group (2020 VS 2024 VS 2031)
5.3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Target Consumer Group (2020-2031)
5.3.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Target Consumer Group (%) (2020-2031)
5.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Target Consumer Group (2020-2031)
6 Segmentation by Core Functional Claim
6.1 Introduction by Core Functional Claim
6.1.1 Anti-aging
6.1.2 Hydrating
6.1.3 Brightening
6.1.4 Others
6.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Core Functional Claim
6.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Core Functional Claim (2020 VS 2024 VS 2031)
6.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Core Functional Claim (2020-2031)
6.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Core Functional Claim (%) (2020-2031)
6.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Core Functional Claim
6.3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Core Functional Claim (2020 VS 2024 VS 2031)
6.3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Core Functional Claim (2020-2031)
6.3.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Core Functional Claim (%) (2020-2031)
6.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Core Functional Claim (2020-2031)
7 Segmentation by Application
7.1 Introduction by Application
7.1.1 Facial Mask
7.1.2 Essence
7.1.3 Lotion
7.1.4 Others
7.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application
7.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application (2020 VS 2024 VS 2031)
7.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Application (2020-2031)
7.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, by Application (%) (2020-2031)
7.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Application
7.3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Application (2020 VS 2024 VS 2031)
7.3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Application (2020-2031)
7.3.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, by Application (%) (2020-2031)
7.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Application (2020-2031)
8 Segmentation by Region
8.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Region
8.1.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Region: 2020 VS 2024 VS 2031
8.1.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Region (2020-2025)
8.1.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Region (2026-2031)
8.1.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Region (%), (2020-2031)
8.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Region
8.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Region: 2020 VS 2024 VS 2031
8.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Region (2020-2025)
8.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Region (2026-2031)
8.2.4 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume by Region (%), (2020-2031)
8.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Region (2020-2031)
8.4 North America
8.4.1 North America Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
8.4.2 North America Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Country (%), 2024 VS 2031
8.5 Europe
8.5.1 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
8.5.2 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Country (%), 2024 VS 2031
8.6 Asia Pacific
8.6.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
8.6.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Region (%), 2024 VS 2031
8.7 South America
8.7.1 South America Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
8.7.2 South America Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Country (%), 2024 VS 2031
8.8 Middle East & Africa
8.8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
8.8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Country (%), 2024 VS 2031
9 Segmentation by Key Countries/Regions
9.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value Growth Trends, 2020 VS 2024 VS 2031
9.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value and Sales Volume
9.2.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.2.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Cosmetics Sales Volume, 2020-2031
9.3 United States
9.3.1 United States Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.3.2 United States Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (%), 2024 VS 2031
9.3.3 United States Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application, 2024 VS 2031
9.4 Europe
9.4.1 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.4.2 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (%), 2024 VS 2031
9.4.3 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application, 2024 VS 2031
9.5 China
9.5.1 China Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.5.2 China Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (%), 2024 VS 2031
9.5.3 China Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application, 2024 VS 2031
9.6 Japan
9.6.1 Japan Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.6.2 Japan Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (%), 2024 VS 2031
9.6.3 Japan Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application, 2024 VS 2031
9.7 South Korea
9.7.1 South Korea Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.7.2 South Korea Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (%), 2024 VS 2031
9.7.3 South Korea Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application, 2024 VS 2031
9.8 Southeast Asia
9.8.1 Southeast Asia Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.8.2 Southeast Asia Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (%), 2024 VS 2031
9.8.3 Southeast Asia Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application, 2024 VS 2031
9.9 India
9.9.1 India Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value, 2020-2031
9.9.2 India Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Type (%), 2024 VS 2031
9.9.3 India Nicotinamide Mononucleotide (NMN) Cosmetics Sales Value by Application, 2024 VS 2031
10 Company Profiles
10.1 Natuore Recover
10.1.1 Natuore Recover Company Information
10.1.2 Natuore Recover Introduction and Business Overview
10.1.3 Natuore Recover Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.1.4 Natuore Recover Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.1.5 Natuore Recover Recent Development
10.2 Mirailab Bioscience
10.2.1 Mirailab Bioscience Company Information
10.2.2 Mirailab Bioscience Introduction and Business Overview
10.2.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.2.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.2.5 Mirailab Bioscience Recent Development
10.3 Eurea
10.3.1 Eurea Company Information
10.3.2 Eurea Introduction and Business Overview
10.3.3 Eurea Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.3.4 Eurea Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.3.5 Eurea Recent Development
10.4 LUERLING
10.4.1 LUERLING Company Information
10.4.2 LUERLING Introduction and Business Overview
10.4.3 LUERLING Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.4.4 LUERLING Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.4.5 LUERLING Recent Development
10.5 RubyBerries
10.5.1 RubyBerries Company Information
10.5.2 RubyBerries Introduction and Business Overview
10.5.3 RubyBerries Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.5.4 RubyBerries Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.5.5 RubyBerries Recent Development
10.6 Winkey Technology
10.6.1 Winkey Technology Company Information
10.6.2 Winkey Technology Introduction and Business Overview
10.6.3 Winkey Technology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.6.4 Winkey Technology Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.6.5 Winkey Technology Recent Development
10.7 GeneHarbor
10.7.1 GeneHarbor Company Information
10.7.2 GeneHarbor Introduction and Business Overview
10.7.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.7.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.7.5 GeneHarbor Recent Development
10.8 Bontac
10.8.1 Bontac Company Information
10.8.2 Bontac Introduction and Business Overview
10.8.3 Bontac Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.8.4 Bontac Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.8.5 Bontac Recent Development
10.9 EffePharm
10.9.1 EffePharm Company Information
10.9.2 EffePharm Introduction and Business Overview
10.9.3 EffePharm Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.9.4 EffePharm Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.9.5 EffePharm Recent Development
10.10 Bloomage Biotechnology
10.10.1 Bloomage Biotechnology Company Information
10.10.2 Bloomage Biotechnology Introduction and Business Overview
10.10.3 Bloomage Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.10.4 Bloomage Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.10.5 Bloomage Biotechnology Recent Development
10.11 Jiangxi Haiwen Biotechnology
10.11.1 Jiangxi Haiwen Biotechnology Company Information
10.11.2 Jiangxi Haiwen Biotechnology Introduction and Business Overview
10.11.3 Jiangxi Haiwen Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.11.4 Jiangxi Haiwen Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.11.5 Jiangxi Haiwen Biotechnology Recent Development
10.12 Futide Health Management
10.12.1 Futide Health Management Company Information
10.12.2 Futide Health Management Introduction and Business Overview
10.12.3 Futide Health Management Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.12.4 Futide Health Management Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.12.5 Futide Health Management Recent Development
10.13 Zein
10.13.1 Zein Company Information
10.13.2 Zein Introduction and Business Overview
10.13.3 Zein Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.13.4 Zein Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.13.5 Zein Recent Development
10.14 Harbin Fuerjia Technology
10.14.1 Harbin Fuerjia Technology Company Information
10.14.2 Harbin Fuerjia Technology Introduction and Business Overview
10.14.3 Harbin Fuerjia Technology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
10.14.4 Harbin Fuerjia Technology Nicotinamide Mononucleotide (NMN) Cosmetics Product Offerings
10.14.5 Harbin Fuerjia Technology Recent Development
11 Industry Chain Analysis
11.1 Nicotinamide Mononucleotide (NMN) Cosmetics Industrial Chain
11.2 Nicotinamide Mononucleotide (NMN) Cosmetics Upstream Analysis
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.2.3 Manufacturing Cost Structure
11.3 Midstream Analysis
11.4 Downstream Analysis (Customers Analysis)
11.5 Sales Model and Sales Channels
11.5.1 Nicotinamide Mononucleotide (NMN) Cosmetics Sales Model
11.5.2 Sales Channel
11.5.3 Nicotinamide Mononucleotide (NMN) Cosmetics Distributors
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Nicotinamide Mononucleotide (NMN) Cosmetics market is projected to grow from US$ 373 million in 2025 to US$ 1375 million by 2032, at a CAGR of 20.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-10
Pages: 157
USD 4900.00
(Single User License)
The global Nicotinamide Mononucleotide (NMN) Cosmetics market size was US$ 373 million in 2025 and is forecast to reach a readjusted size of US$ 1375 million by 2032 with a CAGR of 20.8% during the forecast period 2026-2032.
Published Date: 2026-03-10
Pages: 99
USD 4250.00
(Single User License)
The global Nicotinamide Mononucleotide (NMN) Cosmetics market was valued at US$ 373 million in 2025 and is anticipated to reach US$ 1375 million by 2032, at a CAGR of 20.8% from 2026 to 2032.
Published Date: 2026-03-10
Pages: 123
USD 2900.00
(Single User License)
The global market for Nicotinamide Mononucleotide (NMN) Cosmetics was estimated to be worth US$ 373 million in 2025 and is projected to reach US$ 1375 million, growing at a CAGR of 20.8% from 2026 to 2032.
Published Date: 2026-03-10
Pages: 123
USD 3950.00
(Single User License)
The global market for Nicotinamide Mononucleotide (NMN) Cosmetics was valued at US$ 305 million in the year 2024 and is projected to reach a revised size of US$ 1158 million by 2031, growing at a CAGR of 20.8% during the forecast period.
Published Date: 2025-11-18
Pages: 92
USD 2900.00
(Single User License)
The global Nicotinamide Mononucleotide (NMN) Cosmetics market is projected to grow from US$ 305 million in 2024 to US$ 1158 million by 2031, at a CAGR of 20.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-18
Pages: 155
USD 4900.00
(Single User License)
The global Nicotinamide Mononucleotide (NMN) Cosmetics market size was US$ 305 million in 2024 and is forecast to a readjusted size of US$ 1158 million by 2031 with a CAGR of 20.8% during the forecast period 2025-2031.
Published Date: 2025-11-18
Pages: 93
USD 4250.00
(Single User License)
The global Nicotinamide Mononucleotide (NMN) Cosmetics market is projected to grow from US$ 373 million in 2025 to US$ 1375 million by 2032, at a CAGR of 20.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-10
Pages: 157
The global Nicotinamide Mononucleotide (NMN) Cosmetics market size was US$ 373 million in 2025 and is forecast to reach a readjusted size of US$ 1375 million by 2032 with a CAGR of 20.8% during the forecast period 2026-2032.
Published: 2026-03-10
Pages: 99
The global Nicotinamide Mononucleotide (NMN) Cosmetics market was valued at US$ 373 million in 2025 and is anticipated to reach US$ 1375 million by 2032, at a CAGR of 20.8% from 2026 to 2032.
Published: 2026-03-10
Pages: 123
The global market for Nicotinamide Mononucleotide (NMN) Cosmetics was estimated to be worth US$ 373 million in 2025 and is projected to reach US$ 1375 million, growing at a CAGR of 20.8% from 2026 to 2032.
Published: 2026-03-10
Pages: 123
The global market for Nicotinamide Mononucleotide (NMN) Cosmetics was valued at US$ 305 million in the year 2024 and is projected to reach a revised size of US$ 1158 million by 2031, growing at a CAGR of 20.8% during the forecast period.
Published: 2025-11-18
Pages: 92
The global Nicotinamide Mononucleotide (NMN) Cosmetics market is projected to grow from US$ 305 million in 2024 to US$ 1158 million by 2031, at a CAGR of 20.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-18
Pages: 155
The global Nicotinamide Mononucleotide (NMN) Cosmetics market size was US$ 305 million in 2024 and is forecast to a readjusted size of US$ 1158 million by 2031 with a CAGR of 20.8% during the forecast period 2025-2031.
Published: 2025-11-18
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now